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Abstract
Urinary tract infection (UTI) is one of the most common bacterial infections with frequent
recurrence being a major medical challenge. Development of effective therapies has been
impeded by the lack of knowledge of events leading to adaptive immunity. Here, we establish
conclusive evidence that an adaptive immune response is generated during UTI, yet this
response does not establish sterilizing immunity. To investigate the underlying deficiency,
we delineated the naïve bladder immune cell compartment, identifying resident macro-
phages as the most populous immune cell. To evaluate their impact on the establishment of
adaptive immune responses following infection, we measured bacterial clearance in mice
depleted of either circulating monocytes, which give rise to macrophages, or bladder resident
macrophages. Surprisingly, mice depleted of resident macrophages, prior to primary infec-
tion, exhibited a nearly 2-log reduction in bacterial burden following secondary challenge
compared to untreated animals. This increased bacterial clearance, in the context of a chal-
lenge infection, was dependent on lymphocytes. Macrophages were the predominant anti-
gen presenting cell to acquire bacteria post-infection and in their absence, bacterial uptake
by dendritic cells was increased almost 2-fold. These data suggest that bacterial uptake by
tissue macrophages impedes development of adaptive immune responses during UTI,
revealing a novel target for enhancing host responses to bacterial infection of the bladder.
Author Summary
Urinary tract infection is a common infection with a high propensity for recurrence. The
majority of infections are caused by uropathogenic E. coli, a growing public health concern
with increasing prevalence of antibiotic resistant strains. Finding therapeutic options that
circumvent the need for antibiotics, while boosting patients’ immune response to infection
is desirable to counteract further increases in antibiotic resistance and to provide long-
lasting resistance to infection. Currently, little is known about how adaptive immune
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responses, which typically prevent recurrent infection in other organs, arise from the blad-
der during urinary tract infection. Here, we investigated the initial interactions between
immune cell populations of the bladder and uropathogenic E. coli, finding that macro-
phages are the principal cell population to engulf bacteria. Interestingly, these same cells
appear to inhibit the development of adaptive immunity to the bacteria, as their depletion,
prior to primary infection, results in a stronger immune response during bacterial chal-
lenge. We found that in the absence of macrophages, dendritic cells, which are the most
potent initiators of adaptive immunity, are able to take up more bacteria for presentation.
Our study has revealed a mechanism in which specific immune cells may act in a manner
detrimental to host immunity.
Introduction
Urinary tract infection (UTI) is one of the most common bacterial infections, impacting more
than 130 million people annually worldwide [1,2]. The principal causative agent is uropatho-
genic Escherichia coli (UPEC), accounting for more than 75% of all community acquired infec-
tions, particularly among a seemingly healthy population (e.g., premenopausal women) [1]. In
uncomplicated UTI (i.e., cystitis), nearly half of all women infected will experience recurrence
[3]. Currently, there is little consensus in the field regarding the underlying causes of the high
rate of recurrence. Mechanisms previously proposed to explain this phenomenon include that
UPEC forms protected reservoirs in the bladder, remerging at later time points after initial
infection [4,5]; that UPEC strains colonize the gut and periodically migrate to the urinary tract
[6]; or that the immune response to infection is suppressed by mast cell-derived IL-10 in the
bladder [7].
The innate immune response to UPEC infection is characterized by robust cytokine and
chemokine expression, leading to rapid neutrophil and monocyte infiltration and subsequent
bacterial clearance [8–12]. Depletion of both neutrophils and monocytes, by Gr1 antibody
treatment [13], leads to increased bacterial burden, whereas a reduction in circulating neutro-
phils alone decreases bacterial burden, suggesting that monocytes help eliminate bacteria in the
bladder [10,11]. A recent study demonstrated that innate immune cell crosstalk is necessary for
a coordinated innate response, whereby resident macrophages, responding to signals from
infiltrating monocytes, induce MMP9 expression in neutrophils, in turn facilitating their trans-
urothelial migration [14]. This mechanism likely works in concert with cytokine and chemo-
kine expression from infected urothelium that mediates neutrophil recruitment and trans-
urothelial migration [9].
The mechanisms involved in the initiation of adaptive immunity, and indeed the full nature
of the response generated from the bladder during UTI, remain unclear [15]. The majority of
studies have focused on innate immunity to UTI, such as neutrophil or monocyte infiltration,
while only a limited number of studies have focused on adaptive immune mechanisms [16].
For example, UPEC-specific antibodies arise during UTI in mice, non-human primates, and
human patients, and can inhibit UPEC binding to urothelial cells in vitro [17–19]. With respect
to the role of effector cells, only one study has examined the induction of antigen-specific anti-
body and T cell responses after UPEC infection, demonstrating that transfer of serum or T
cells from infected animals limits infection in naïve mice [19].
In this study, we investigated the initiation of adaptive immunity to UPEC to determine
whether defects exist preventing the induction of sterilizing immunity. We conclusively dem-
onstrated that adaptive immune responses are generated in response to UPEC infection;
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however, they are insufficient to prevent reinfection. We performed the first systematic analysis
of the tissue-resident immune cell compartment in the steady state bladder of mice and investi-
gated the role of macrophages, and their precursors, in the adaptive immune response during
UTI. Strikingly, macrophage depletion, prior to primary infection, improved adaptive immune
responses to challenge infection in a macrophage-replete environment. We observed that upon
infection, macrophages were the principal population, among the antigen presenting cells, to
acquire UPEC early in infection, and in their absence, bacterial uptake by dendritic cells (DCs)
was increased. These data support a model in which bladder-resident macrophages sequester
bacteria, consequently limiting adaptive immune responses, and provides an explanation for
the failure of the immune system to respond effectively to UPEC infection.
Results
UPEC infection primes an adaptive immune response mediated by DCs
Surprisingly, no study has directly tested the necessity of an adaptive immune response to limit
UPEC reinfection or the role of specific components of the adaptive immune system in gener-
ating these responses. We employed a model of UPEC-induced cystitis in which 107 colony-
forming units (CFU) of UPEC isolate UTI89, made resistant to either ampicillin or kanamycin,
were instilled intravesically into 7–8 week old female wildtype C57Bl/6 or C57Bl/6 RAG2-/-
mice [20]. Animals were sacrificed at 24 hours post-infection (P.I.) to assess bacterial burden
or monitored for bacteriuria to evaluate the resolution of acute infection, defined by the
absence of bacteria in the urine. Three to four weeks later, when the mice had resolved the pri-
mary infection, animals were challenged with 107 CFU of an isogenic UPEC strain, resistant to
the antibiotic not employed for primary infection, and sacrificed 24 hours P.I. to evaluate bac-
terial clearance (Fig 1A). Importantly, the use of isogenic UPEC strains, differing only by anti-
biotic resistance and fluorescent marker, permitted differentiation between quiescent bacteria
residing in reservoirs established during primary UPEC infection [5] and the challenge strain.
Of note, this distinction has not been made in previous reports, and thus it has remained
unclear whether bacteria measured in the bladder after challenge infection derive from the pri-
mary or challenge infection, or represent a mixture of both infections [19]. After UPEC chal-
lenge in wildtype mice, we observed a>2 log reduction in CFU of the challenge UPEC strain
compared to the bacterial burden 24 hours after primary infection (Fig 1B). By contrast, the
bacterial burden after challenge infection in RAG2-/- mice was similar to that after primary
infection (Fig 1B).
As DCs are the principal cells to present antigen to lymphocytes, we investigated their role
in inducing an adaptive immune response following a primary infection. Utilizing CD11c-
DTR chimeric mice, we depleted CD11c-expressing DCs, prior to primary infection, by admin-
istration of two doses of diphtheria toxin (S1 Fig). As previously reported, diphtheria toxin
treatment also impacted the number of tissue resident macrophages (S1 Fig and [21]); however,
this reduction was minimal and the number of macrophages present in toxin-treated mice was
within the range of normal variance (Table 1). Twenty-four hours after depletion, we infected
mice as described in Fig 1A, and followed resolution of infection by assessing bacteriuria.
Upon resolution of the primary infection, mice were challenged with an isogenic UTI89 strain,
as described above. To measure the bacterial burden following primary infection in the chime-
ric mice, an additional cohort of naïve, untreated chimeric mice received a primary infection at
the same time as the infected animals received the challenge infection (Fig 1C, 1° group). We
assessed bacterial burden at 24 hours following primary or challenge infection and observed
that animals treated with PBS were better able to clear UPEC after challenge compared to DC-
depleted animals (Fig 1C). Together, these results suggest that the reduction in CFU observed
Macrophages Limit Adaptive Immunity to UTI
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Fig 1. An adaptive immune response is necessary for bacterial clearance during UPEC challenge
infection. (A) Experimental scheme used in the study. (B) Female C57Bl/6 (WT) or RAG2-/- mice were
instilled with UTI89 and sacrificed 24 hours P.I. (1°) or challenged with an isogenic UPEC strain carrying a
different antibiotic marker and sacrificed 24 hours P.I. (2°) to evaluate bacterial burden. (C) 12 weeks post-
reconstitution, chimeric CD11c-DTRmice were treated with PBS or diphtheria toxin (DT) to eliminate DCs
and infected with UTI89 24 hours post treatment. Mice were challenged with the isogenic UPEC strain and
sacrificed 24 hours P.I. to measure CFU/bladder (2°). At the time of the challenge infection in (C), an
additional group of naïve CD11c-DTR chimeric mice was infected with UTI89 to evaluate CFU after a primary
UPEC infection (1°). (D-E) Graphs depict CFU/bladder of the primary strain from the infections in (B) and (C),
respectively. Each dot represents one mouse, lines are medians. Experiments were performed 2 times with
5–7 mice per group in each experiment. *p = 0.0221, Mann-Whitney.
doi:10.1371/journal.ppat.1005044.g001
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after a challenge infection is mediated by an adaptive immune response, dependent upon DCs
and lymphocytes. Interestingly, this response to UPEC reduces bacterial burden but does not
prevent re-infection after challenge (Fig 1 and [19]).
Finally, in our model, approximately 10% of the total CFU measured after a challenge infec-
tion arose from the primary infecting strain, representing the reservoir formed during infec-
tion. These bacteria appeared to be protected from host clearance mechanisms, as no
differences in the number of bacteria present in the reservoir between wildtype and RAG2-/-
mice (Fig 1D), or PBS and DT-treated CD11c-DTR mice were observed (Fig 1E).
The bladder contains a diverse immune cell repertoire
To understand how adaptive immune responses are initiated in the bladder, we began by inves-
tigating the resident immune cell compartment of the bladder. Earlier studies have described
bladder-resident DCs [22–25], however, a comprehensive analysis of all immune cell popula-
tions has not been previously performed. Thus, we executed a systematic analysis of the blad-
der-resident CD45+ immune cell compartment. Bladders from naïve C57Bl/6 mice were
enzymatically digested and immunostained (Materials and Methods, Table 2). As the bladder’s
broad autofluorescent signal interfered with immune cell detection, we developed a gating
strategy to exclude nonhematopoietic autofluorescent cells during analysis (S2A–S2C Fig).
Antigen presenting cells (APCs), defined as MHC II+, comprised the majority of CD45+ cells
(69% ± 7.5 of CD45+ cells, Fig 2A and 2E). Macrophages, delineated by CD64 [26,27] and F4/
80 co-expression, were by far the largest APC population (~40% of CD45+ cells) (Fig 2B and
2E). The CD11b+ and CD103+ dendritic cell (DC) subsets represented 15% and 5% of CD45+
cells, respectively (Fig 2B and 2E). Within the MHC II- CD11b- gate, we identified NK1.1+ NK
cells, CD11blo-int cKit+ IgE+ mast cells [28], CD3+ CD4+, and CD3+ γδ+ T cells, but never
observed CD8+ T cells in naïve bladders (Fig 2C and 2E). Recently, it was reported that classical
Ly6C+ monocytes constitutively traffic into naïve nonlymphoid tissues, such as skin, in the
steady state [29,30]. Accordingly, in the MHC II- CD11b+ gate, we identified resident Ly6C+
monocytes as well as SiglecF+ eosinophils [31] (Fig 2D and 2E). Notably, no neutrophils were
observed in naïve bladders.
Infiltrating classical monocytes differentiate to macrophages during
infection
In addition to neutrophils, monocytes infiltrate the bladder upon UPEC infection [8,11]. To
determine the fate of infiltrating monocytes, we employed in vivo labeling of circulating
Table 1. Immune cell populations in naïve bladders.
Naïve bladder
Cell subset Cell numbera
CD45+ 35714 ± 11161
Macrophages 9035 ± 3480
CD11b+ DCs 4046 ± 1785
CD103+ DCs 1011 ± 443
Monocytes 720 ± 467
a Cell numbers are displayed as the mean ± the standard deviation. Values are derived from at least 8
mice, analyzed in separate experiments.
doi:10.1371/journal.ppat.1005044.t001
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monocytes to monitor their entry into infected bladders [8,32]. Mice were infected 24 hours
after labeling circulating classical or nonclassical monocytes and sacrificed at 4, 24, and 48
hours P.I., for analysis by flow cytometry. In line with observations from other infection mod-
els [33,34], a greater number of classical monocytes infiltrated the bladder over time than non-
classical monocytes (Fig 3A, note the scales of the y-axes). In the classical labeling protocol, a
majority of infiltrated bead+ cells upregulated CD11c, MHC II, and CD64 expression, and
downregulated CD11b and Ly6C from 24 to 48 hours P.I., phenotypically resembling resident
macrophages (gray histograms) (Fig 3B). The percentage of bead+ cells that were identified as
macrophages increased from 24 to 48 hours, while only 10% of all bead+ cells had a DC pheno-
type (Fig 3C), supporting the conclusion that infiltrating classical monocytes predominantly
differentiate into macrophages during UTI.
Depletion of bladder-resident macrophages improves adaptive immunity
to UPEC
During infection, infiltrating monocytes increased the already substantial macrophage com-
partment, thus we hypothesized that monocyte-derived and/or resident macrophages might
play an important role during UPEC infection. To test this hypothesis, we depleted each popu-
lation separately to determine the impact on bacterial burden. Circulating monocytes, but not
bladder-resident macrophages, were depleted with clodronate liposomes [35] (S3A and S3B
Fig), and mice were infected 15–18 hours later with UPEC. Mice were sacrificed 24 hours P.I.
to determine CFU. Monocyte-depleted animals had a small (<1-log) but significant improve-
ment in bacterial elimination 24 hours P.I. (Fig 4A). This difference, however, was lost if mice
were infected 24 hours post-clodronate treatment, when monocytes have begun to repopulate
Table 2. Antibodies used in this study.
Molecule Clone Vendor
CD3 145-2C11 BD Bioscience
CD4 RM4-5 BD Bioscience
CD4 GK1.5 BD Bioscience
CD8 53–6.7 BD Bioscience
CD45 30-F11 BD Bioscience
CD64 X54-5/7.1 BD Bioscience
CD103 M290 BD Bioscience
CD115 AFS98 eBioscience
CD11b M1/70 BD Bioscience
CD11c N418 eBioscience
c-Kit 2B8 BD Bioscience
F4/80 CI:A3-1 AbD Serotec
gammadelta TCR GL3 eBioscience
Gr1 RB6-8C5 BD Bioscience
IgE R35-72 BD Bioscience
Ly6G 1A8 BD Bioscience
Ly6C AL-21 BD Bioscience
MHC-II (I-A/I-E) M5/114.15.2 eBioscience
NK 1.1 PK136 BD Bioscience
Nkp46 29A1.4 BD Bioscience
SiglecF E50-2440 BD Bioscience
doi:10.1371/journal.ppat.1005044.t002
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Fig 2. The bladder contains a diverse immune cell repertoire. Naïve bladders from female C57Bl/6 mice were digested for flow cytometry. Single cell
preparations were stained with antibodies indicated in Table 2. (A) Single, CD45+ cells were gated into 3 groups (i-iii) according to their CD11b and MHC II
expression levels. (B) MHC II+ cells from gate (i) were divided into 3 populations, F480+ CD64+ macrophages (pink gate), CD11b+ DCs (blue gate) and
CD103+ DCs (green gate). The expression levels of MHC II, CD64, F4/80, CD11c, CD103, and CD11b are depicted in the histograms (macrophages—pink
lines, CD11b+ DCs—blue lines, CD103+ DCs—green lines). (C) MHC II- CD11b- cells from gate (ii) were subdivided by their expression of CD3 and NK1.1.
CD3+ cells were divided into CD4+ and TCR γδ+ and the CD3- gate shows cKit+ IgE+ mast cells. (D) The dot plot, from gate (iii) depicts MHC II- CD11b+
Macrophages Limit Adaptive Immunity to UTI
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the circulation, suggesting that monocyte depletion has a transient impact on bacterial burden.
Supporting this conclusion, there were no differences in bacterial burden 24 hours P.I. in
CCR2-/- mice (S4 Fig), which have greatly reduced numbers of circulating monocytes [33], as
compared to wildtype mice.
Bladder-resident macrophages were eliminated by administration of anti-CSF1R depleting
antibody 24 hours prior to infection (S3C Fig) [36]. Importantly, the anti-CFS1R antibody also
targeted monocytes, however these cells were not completely eliminated from circulation at the
time of infection (compare S3A Fig to S3D Fig). Mice depleted of macrophages had a similar
bacterial burden at 24 hours P.I. compared to non-depleted mice (Fig 4B) suggesting that the
absence of macrophages does not impact UPEC clearance at early time points P.I.
As macrophage depletion had no impact on the primary infection, we considered whether
their absence might influence the generation of an adaptive immune response. Indeed, macro-
phages can impact adaptive immunity via cytokine secretion or antigen sequestration. To
directly test the influence of monocytes and macrophages on the generation of adaptive immu-
nity during UTI, we depleted each of these cell types, as above. To address the role of mono-
cytes, mice were depleted by clodronate treatment, infected, and subsequently challenged with
an isogenic UTI89 strain and sacrificed at 24 hours P.I. to determine CFU, as in (Fig 1A). We
did not observe a difference in bacterial burden at 24 hours post-challenge (Fig 4C) or in reser-
voir formation (S5 Fig), suggesting that the absence of monocytes, before primary infection,
did not influence bacterial clearance after challenge infection. Further, these data demonstrate
that the small improvement observed in bacterial clearance at 24 hours post-primary infection
after clodronate treatment (Fig 4A), did not influence the development of an adaptive immune
response to the bacteria.
To determine whether resident macrophages influence bacterial clearance after challenge,
we treated mice with anti-CSF1R and infected with UPEC. Upon resolution of the primary
infection, mice were challenged with an isogenic UTI89 strain and bacterial burden determined
24 hours post-challenge. In the course of the experiment, macrophage depletion did not impact
reservoir formation (S5 Fig). Despite similar clearance during the primary infection, we
observed a surprising reduction of nearly 2 orders of magnitude in CFU after challenge infec-
tion of mice depleted of macrophages prior to the primary infection as compared to control
isotype-treated and untreated (infected and challenged, but not receiving antibody injection)
mice (Fig 4D). Importantly, at the time of the challenge infection, macrophages had repopu-
lated the bladder in depleted animals, ruling out the possibility that bacterial burden was influ-
enced by the absence of macrophages during challenge infection (S3E Fig).
To test whether this improvement in bacterial clearance in the absence of macrophages was
dependent upon components of the adaptive immune system, we depleted macrophages in
RAG2-/- mice. We observed no difference in the CFU per bladder after UPEC challenge
between macrophage-depleted or control treated RAG2-/- mice (Fig 4E). To specifically assess
the necessity of T cells, we depleted macrophages in mice that had been treated with CD4 and
CD8 depleting antibodies prior to primary infection. We observed fewer UPEC post-challenge
only in macrophage-depleted mice that were replete of their T cells. However, mice depleted of
CD4+ and CD8+ T cells did not demonstrate improved bacterial clearance after challenge inde-
pendently of macrophage depletion (Fig 4F). Together, these results support the conclusion
F480int/+ eosinophils (purple gate) and monocytes (orange gate). Histograms depict expression levels of SiglecF and Ly6C from gate (iii) (eosinophils—
purple lines, monocytes—orange lines). (E) Graphs depict immune cell populations in the naïve bladder as percentage of all CD45+ cells. Representative
cytometry dot plots and histograms from different individual bladders are depicted, with the exception of the mast cell plot in (C), which depicts three pooled
bladders due to the low number of mast cells. In (E), each dot represents one bladder, lines are medians, plots are pooled from three or more experiments.
doi:10.1371/journal.ppat.1005044.g002
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Fig 3. Classical monocytes robustly enter the bladder and becomemacrophages. In naïve C57Bl/6 mice, monocyte subsets were labeled in vivo as
described in Materials and Methods. The designation “classical mo” and “nonclassical mo” indicates the monocyte subset labeled. Mice were infected with
UTI89 24 hours after monocyte labeling and sacrificed at 4, 24, and 48 hours P.I. for flow cytometry. (A) Representative cytometry plots are shown, where
gated bead+ cells (blue) are overlaid on all CD45+ bladder cells (gray). Graphs depict the quantitation of infiltrating monocytes over time, note difference in y-
axis. (B) Histograms show the bead+ cell phenotype in the bladder over time after classical monocyte labeling (red lines—24 hours P.I., blue lines—48 hours
P.I., and gray histograms—resident macrophages at 4 hours P.I., for reference). (C) Graphs show the percentage of all bead+ CD45+ cells after classical
monocyte labeling in infected bladders by immune cell subset at 24 and 48 hours P.I. Each dot is one mouse, lines are medians. In (A) and (B), single
representative bladders are displayed. Experiments were performed 3 times with 3–5 mice per group.
doi:10.1371/journal.ppat.1005044.g003
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Fig 4. Macrophage depletion improves the adaptive response to UPEC infection.Graphs show CFU per
bladder 24 hours post primary infection (A) in mice treated with PBS or clodronate liposomes (Clod) to
deplete monocytes 15–18 hours prior to infection and (B) in mice treated 24 hours prior to primary infection
with isotype control (Iso) or CSF1R antibody (Ab). (C-F) Mice were given a primary infection, allowed to
resolve, and 3 to 4 weeks P.I., mice were challenged with an isogenic UPEC strain, as in Fig 1A. Graphs
show CFU per bladder 24 hours post challenge infection in (C) wildtype mice treated with PBS or clodronate-
loaded liposomes (Clod) to deplete monocytes 15–18 hours prior to primary infection, (D) isotype (Iso) or
Macrophages Limit Adaptive Immunity to UTI
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that macrophage depletion at the time of primary infection positively impacts the capacity to
generate a T cell-dependent adaptive immune response against UPEC.
Effector cell infiltration and cytokine secretion are unchanged after
macrophage depletion during infection
To investigate potential mechanisms mediating improved clearance after macrophage deple-
tion in a challenge infection, we first focused on events following the challenge. We depleted
macrophages and infected mice as above. When all mice had resolved the primary infection,
we challenged the mice and 24 hours post-challenge, mice were sacrificed. We assessed
immune cell infiltration into the bladder by flow cytometry and surprisingly, we did not
observe differences in the number of T cells, B cells, neutrophils, or monocytes infiltrating the
bladder after challenge infection (Fig 5A and 5B). These data suggest that improved bacterial
clearance is not mediated by increased numbers of innate or effector cells. In addition to cell
infiltration, we evaluated UPEC-specific IgA in the urine over time, however, the levels of
UPEC-specific IgA were at the limit of detection of the assay, as has been reported in other
studies [7].
Macrophages can influence the generation of an adaptive immune response through the
modulation of the cytokine microenvironment [37,38]. Thus, we evaluated cytokine expression
in the bladder 24 hours after a primary infection in control or antibody-treated mice by lumi-
nex technology. Notably, we did not observe significant differences between isotype-treated
and antibody-depleted mice in any of the 32 cytokines evaluated (Fig 5C and S6 Fig), suggest-
ing that cytokine expression is not significantly impacted at this timepoint in infection.
Macrophages are the predominant APC to acquire UPEC early after
infection
Given that we found no differences in effector cell infiltration or cytokine expression, we con-
sidered whether macrophages sequester bacteria during infection. To test which immune cells
acquire UPEC during infection, we utilized our kanamycin-resistant UTI89 strain, which also
expresses MARS red fluorescent protein (UTI89-RFP) (S7A and S7B Fig). Importantly, when
we infected mice with our ampicillin-resistant UTI89 strain expressing GFP, we could not
clearly differentiate between UTI89-GFP-containing cells and the background autofluores-
cence of bladder macrophages (S7A Fig) or urothelial cells (S2 Fig). Importantly, UTI89-RFP
had similar infectivity in vitro and in vivo compared to the parental UTI89 strain and
UTI89-GFP (S7C and S7D Fig). Mice were instilled with 107 CFU of UTI89-RFP and sacrificed
at 4, 24, and 48 hours P.I. to analyze their bladders by flow cytometry. UTI89-RFP-containing
cells were identified by gating CD45+ cells with RFP fluorescence levels greater than those in
bladders infected with the non-fluorescent parental UTI89 strain (Fig 6A) and their pheno-
types were determined based on expression of cell-specific markers as in Fig 2. At 4 hours P.I.,
the majority of UTI89-RFP+ cells were in the MHC II+ cell compartment. At 24 and 48 hours
P.I., UTI89-RFP+ cells were evenly distributed between the MHC II+ and II- gates (Fig 6B). The
MHC II- cells containing bacteria at 24 and 48 hours were primarily CD11b+ Ly6G+ Ly6C+
CSF1R antibody (Ab) treated mice to deplete resident macrophages 24 hours prior to primary infection, or left
untreated (Untx), (E) RAG2-/- mice treated with isotype (Iso) or CSF1R antibody (Ab) prior to primary infection
or, (F) wildtype mice treated with isotype (Iso) or CSF1R antibody (Ab) to deplete resident macrophages and
isotype (Iso) or anti-CD4 and anti-CD8 antibodies (Abs) to deplete T cells, prior to primary infection. Each dot
is one mouse, lines are medians. Experiments were performed 2–4 times with 4–7 mice per group.
**p = 0.0021, Mann-Whitney; ns: not significant.
doi:10.1371/journal.ppat.1005044.g004
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neutrophils and CD11b+ Ly6G- Ly6C+ monocytes. Among the UPEC+ MHC II+ cells, the
majority exhibited a macrophage phenotype (Fig 6C). Notably, two subpopulations were dis-
tinguishable in the macrophage gate at 24 and 48 hours P.I., representing resident (CD64hi F4/
80hi Ly6C-) and monocyte-derived macrophages (CD64int F4/80int Ly6C+) (Fig 6C). Indeed,
while the number of DCs harboring UTI89-RFP changed very little, the number of macro-
phages containing bacteria increased more than 7-fold at 24 hours and remained elevated at 48
hours (Fig 6D). At all timepoints analyzed, macrophages harbored approximately 60–80% of
the bacteria found within the MHC II+ APC compartment, demonstrating that macrophages
were the primary cell type to phagocytose bacteria at early timepoints post-infection (Fig 6E).
Fig 5. Macrophage depletion does not impact effector cell infiltration or cytokine expression. (A-B) Female C57Bl/6 mice were infected and then
challenged with UPEC after resolution of their primary infection, as in Fig 1A. Twenty-four hours post-challenge, cellular infiltration into the bladder was
evaluated by flow cytometry. Graphs depict cell number per bladder of the indicated populations. Experiment was repeated 3 times with 5–7 mice per group.
(C) Mice were depleted with anti-CSF1R antibody and infected with 1x107 CFU of UTI89 24 hours after depletion. Mice were sacrificed 24 hours P.I. and
bladders were homogenized. Samples were stored at -80°C until all samples could be assessed together by Luminex multi-analyte profiling. Graphs depict
the expression levels of selected cytokines in isotype antibody treated (black dots) and depleting-antibody treated (open circles) mice. Analytes are grouped
by high expression (left graph) and low or no expression (right graph). Each dot represents a mouse, experiment performed 2 times with 5 mice per group and
pooled, lines are medians. Additional analytes are shown in S6 Fig.
doi:10.1371/journal.ppat.1005044.g005
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Macrophage depletion leads to increased phagocytosis of UPEC by
DCs
Macrophages can influence the generation of an adaptive immune response by antigen seques-
tration, as has been observed in the lung, hindering antigen presentation and subsequent T cell
priming by DCs [39–42]. More specifically, it has been proposed that DC migration and the
induction of adaptive immunity can only occur in the lung after the phagocytic capacity of
macrophages has been saturated and excess antigen is available to DCs [42,43]. To test the
hypothesis that antigen availability during primary infection impacted initiation of an adaptive
response during UTI, we infected untreated mice with 107, 108, or 109 CFU of UPEC. When
the animals had resolved the infection, they were challenged with 107 CFU of an isogenic
UPEC strain and 24 hours post-challenge, sacrificed to determine bacterial burden. Notably,
we did not observe a difference in the number of bacteria per bladder after a primary challenge
despite increasing the inoculum 100-fold (S8A Fig). Furthermore, we did not observe any
Fig 6. Macrophages preferentially take up UPEC at early times post-infection. Female C57Bl/6 mice were instilled with UTI89-RFP and bladders were
processed for flow cytometry at 4, 24, and 48 hours. (A) Representative plots, gated on CD45+ cells, depict the fluorescence level of UTI89-RFP in bladders,
as compared to bladders infected with the nonfluorescent parental UTI89 strain. (B) Graphs depict the distribution of UPEC between MHC II+ and MHC II- cell
populations (gated first on CD45+ cells) over time. (C) Representative flow plots display the distribution of bacteria in the MHC II+ cell populations by overlay
of bacteria+ cells (blue) on top of all CD45+ cells (gray). (D) Graph depicts the number of UPEC+ macrophages and DCs over time. (E) Graphs show the
distribution of UPEC in CD45+ MHC II+ macrophages and DCs as a percentage of UPEC acquired by all MHC II+ cells. In (B) and (E), each dot represents
one mouse, lines are medians. In (A) and (C), single representative bladders are depicted. Experiments were performed 4 times with 4–7 mice per group and
results pooled in (B), (D), (E).
doi:10.1371/journal.ppat.1005044.g006
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differences in bacterial burden after challenge among the three groups (S8B Fig). Thus, increas-
ing the number of bacteria during primary infection did not improve the generation of an
adaptive immune response during UTI, however it is possible that we did not saturate bladder
resident macrophages with bacteria.
To directly test whether macrophages were physically sequestering UPEC in the bladder
during UTI, we evaluated bacteria uptake in the bladder in the context of macrophage deple-
tion. Mice were depleted or not of macrophages by anti-CSF1R antibody, infected with
UTI89-RFP and sacrificed 24 hours P.I. The distribution of UPEC was altered in mice depleted
of macrophages as compared to the control group. More bacteria localized to MHC II- cells
(Fig 7A and 7B), potentially explaining why macrophage depletion did not impact bacterial
clearance after primary infection. The percentage of neutrophils containing bacteria was specif-
ically increased in macrophage-depleted mice, likely compensating for the lack of monocytes
and resident macrophages (Fig 7B). In MHC II+ cell populations, while the total number of
DCs in infected bladders was unchanged (Fig 7C), we observed a significantly greater percent-
age of DCs had taken up UPEC in macrophage-depleted animals (Fig 7D). Notably, the per-
centage of UPEC-containing resident and MHC II+ monocyte-derived macrophages was not
different between the isotype and depleting antibody groups (Fig 7E).
Discussion
UTI is unusual in that it is a common infection that recurs with high frequency, particularly in
otherwise healthy adult women [1], suggesting a defect exists in the ability to mount an adap-
tive immune response to UPEC. We observed that the absence of B and/or T cells or DCs
impaired the host’s capacity to clear bacteria after a challenge infection, confirming that adap-
tive immune responses are primed during UTI. Although this was an expected result, surpris-
ingly, it has never been formally demonstrated in the literature until now. We further
demonstrated that while immune responses are primed, they neither prevent reinfection nor
eliminate the bacterial reservoir established during primary infection. To shed light on poten-
tial mechanisms preventing the development of effective adaptive immunity to UPEC infec-
tion, we focused on the role of MHC II+ cells as they are the key initiators of adaptive
immunity. Unexpectedly, in the context of a challenge infection, resident macrophage deple-
tion improved the host’s ability to eliminate bacterial load. Importantly, macrophages were
depleted prior to the first infection; however, they were present in normal numbers at the time
of challenge infection. Notably, this improvement was dependent on the adaptive immune sys-
tem as the phenotype was lost when macrophages were depleted in RAG2-/- mice or in mice
depleted of T cells. Given that macrophages were the principal APC to acquire UPEC early in
infection, these data suggest that macrophages subvert initiation of a robust adaptive immune
response during UTI.
To understand the mechanism of macrophage subversion of adaptive immunity during
UTI, we evaluated events post-challenge and post-primary infection. We observed a significant
infiltration of T cells and a smaller infiltration of B cells post-challenge but no major differ-
ences in cell numbers between the control and treated groups. At this time, we cannot rule out
potential qualitative differences in the activation or specificity of the infiltrating effector cells,
including T cells or possibly NK T cells, which may play a role in kidney infection [44]. As
macrophages repopulated the bladder before challenge infection, we hypothesized that the
impact on adaptive immunity occurred in the first few hours or days following primary infec-
tion. To explore the possibility of antigen sequestration, we evaluated which immune cell popu-
lations acquired UPEC in the bladder in the absence of macrophages. We observed an increase
in the percentage of DCs containing bacteria. DCs are key players in initiating adaptive
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Fig 7. Dendritic cells acquire more bacteria in the absence of macrophages.Macrophages were
depleted or not and mice were infected. Twenty-four hours post-primary infection, bladders were analyzed by
flow cytometry to determine distribution of UPEC in (A) the MHC II- and MHC II+ compartments, (B)
neutrophils and monocytes. (C) Plot depicts the total number of DCs present in the bladder 24 hours post-
primary infection. (D-E) Plots depict the percentage distribution of UPEC in the MHC II+ compartment by cell
population (D) DCs and (E) resident macrophages and monocyte-derived macrophages. Each dot
represents one mouse, lines are medians. Experiments were repeated 3 times with 4–7 mice per group in
each experiment and results pooled. p-values indicated on graphs, Mann-Whitney test.
doi:10.1371/journal.ppat.1005044.g007
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immune responses, and we found that they can do so from the bladder mucosa in the context
of UTI. Indeed, even a partial depletion of bladder-resident DCs, prior to primary infection,
rendered animals less capable of clearing bacteria after challenge infection. The intermediate
clearance phenotype observed in DT-treated mice may have been mediated by DCs remaining
after depletion or by DCs repopulating the tissues before the primary infection was resolved,
permitting delayed antigen presentation. Thus, our data suggest that the more efficacious adap-
tive immune response against UPEC observed during macrophage depletion may be mediated
by the increase in the percentage and number of DCs carrying bacteria. Notably, however, the
proportion of DCs containing UPEC in infected bladders was less than 5% of total DCs present
in mice, suggesting that only a very small number of antigen-carrying DCs are required to
mount an adaptive immune response during UTI.
Macrophages outnumbered DCs in both naïve and infected bladders and were the principal
cell to acquire UPEC. Our findings contradict a recent study in which Schiwon et al. suggest
that bladder-resident macrophages sense UPEC infection, but do not phagocytose bacteria
[14]. As an explanation for this apparent discrepancy, we found that MHC II+ cells containing
GFP-expressing bacteria were indistinguishable from autofluorescent but uninfected cells. We
engineered UTI89 to express a red fluorescent protein to specifically overcome the challenge of
distinguishing naturally autofluorescent cells in the bladder (e.g., macrophages and urothelial
cells) from those containing UPEC. Lending credence to this interpretation, the authors also
did not detect GFP-expressing UPEC in urothelial cells [14], which are invaded during the
course of UTI, as their autofluorescence also likely masked the GFP signal [45,46].
We evaluated macrophages because of their prominent role in bacterial acquisition. How-
ever, even when the majority of UPEC was captured by macrophages at early timepoints P.I.,
their depletion did not impact bacterial clearance after the primary infection. This apparent
contradiction may be explained by the increased bacterial uptake by neutrophils observed in
the absence of macrophages. Our data support a model in which macrophages sequester bacte-
ria from DCs early in infection, however we cannot rule out that depletion of macrophages
alters the microenvironment during infection, despite our negative findings in bladder homog-
enates. Indeed, a recent study suggests that IL-10 expression from mast cells suppresses adap-
tive immunity to UPEC [7]. However, in the course of our study, we found few mast cells in
naïve bladder tissue. Furthermore, multi-analyte cytokine analysis revealed no striking differ-
ences between control and depleted mice and we could not detect IL-10 expression in this or a
prior study [11]. The reasons for this are unclear, however may be due to the significant varia-
tion that exists in the genomes of commonly used strains such as cystitis strain UTI89, pyelone-
phritis strains J96, 563, CFT073, and clinical isolates (see phylogenetic tree in [47]).
Having defined an early role for resident macrophages and DCs during UTI, our work sig-
nificantly advances the understanding of how adaptive responses to UPEC are achieved. How-
ever, we still do not completely understand how the adaptive immune system eliminates
UPEC. Though we were not able to detect UPEC-specific antibodies above the limit of detec-
tion of our assay, others have identified that antibodies against the bacteria are generated dur-
ing infection [17–19]. Thus, we hypothesize that the protection induced during UTI following
a primary infection is mediated by an antibody response; however T cells may also play a criti-
cal role in the killing of infected cells. With respect to the role of the bladder macrophage, our
data point to a barrier in the immune system that must be overcome, particularly for patients
with recurrent UTI. Although macrophage sequestration of particulate antigen in the lung has
been described, this is, to the best of our knowledge, the first study to propose a role for the
physical sequestration of antigen during live bacterial infection. Strategies that increase DC
number or migration may overcome the subversion imposed by macrophages, providing a via-
ble solution to treat patients with recurrent UTI.
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Materials and Methods
Ethics statement
At Mount Sinai School of Medicine, mouse experiments were conducted in accordance with
approval of protocol number LA11-00003 by the Institutional Animal Care and Use Commit-
tee at Mount Sinai School of Medicine, which adheres to the guidelines put forth by the Animal
Welfare Act and the Public Health Service policy on Humane Care and Use of Laboratory Ani-
mals. At Institut Pasteur, mouse experiments were conducted in accordance with approval of
protocol number 2012–0024 by the Comité d’éthique en expérimentation animale Paris Centre
et Sud (the ethics committee for animal experimentation), in application of the European
Directive 2010/63 EU. In our experiments, mice were anesthetized either by inhalation of iso-
flurance (3–4%) or by injection of 100 mg/kg ketamine and 5 mg/kg xylazine and sacrificed
either by cervical dislocation or carbon dioxide inhalation.
Bacterial strains
The human UPEC cystitis isolate, UTI89 (kind gift from Scott Hultgren) [46], and the fluores-
cent protein-expressing strains UTI89-RFP and UTI89-GFP were used for infection. Briefly,
fluorescent bacteria were engineered using lambda red recombination [48] to introduce an
aphA-marsRFP or bla-GFP cassette in the UTI89 chromosome at the attB lambda phage inte-
gration site. UTI89 is sensitive to antibiotics, UTI89-RFP is resistant to kanamycin, and
UTI89-GFP is resistant to ampicillin. Bacteria were grown overnight in static cultures at 37°C
in Luria-Bertani broth (LB) in the presence of antibiotics (kanamycin 50 μg/mL or ampicillin
100 μg/mL) where appropriate.
Cell lines and in vitro invasion assay
The mouse urothelial cell line NUC-1 [49] was used to evaluate the in vitro invasion efficacy of
each UTI89 strain. Fifty thousand cells were infected with UTI89, UTI89-GFP, or UTI89-RFP
at increasing MOIs. Thirty minutes post-infection, cells were washed, lysed, and serial dilutions
were plated. Percent invasion was calculated by dividing the number of bacteria inside the cells
by the inoculum x 100.
Mice and infections
Female C57BL/6 mice between 6 and 8 weeks old were from The Jackson Laboratory or Charles
River. CD11c-DTR mice were a kind gift fromMarc Lecuit and Claude LeClerc (Institut Pas-
teur). RAG2-/- mice were a kind gift from Antonio Freitas (Institut Pasteur). Briefly, mice anes-
thetized with isoflurance (4%) or 100 mg/kg ketamine and 5 mg/kg xylazine were infected with
107 colony-forming units (CFU) of one of two UTI89 strains in 50 μL PBS via a catheter intro-
duced into the urethra [20] except in the inoculum escalating experiment, where mice received
107, 108 or 109 CFU in 50 μL PBS. To calculate CFU, bladders were aseptically removed and
homogenized in 1 mL PBS. Serial dilutions were plated on LB agar, with or without antibiotics,
as required. For challenge infection experiments, mice were infected with one of the two fluo-
rescent strains of UTI89, expressing antibiotic resistance (kanamycin or ampicillin) (See Fig
1A). Once the primary infection cleared, 3 to 4 weeks, mice were infected with 107 CFU of an
isogenic UTI89 strain with a different antibiotic resistance. The strain used for the challenge
infection was determined by that used in the primary infection, such that the antibiotic resis-
tances were different between the primary and challenge infection, e.g., UTI89-GFP for the pri-
mary and UTI89-RFP for the challenge infection. Importantly, both strains were used as the
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primary or the challenge strain in different experiments. Resolution of infection was monitored
by plating urine every 5–6 days on antibiotic-containing plates.
Irradiation, bone marrow cell transfer, diphtheria toxin treatment
C57Bl/6 mice were irradiated with a single dose of 5–6 gray in an x-ray irradiator at 6 weeks of
age. Animals were reconstituted with 1.6–3.2 x 106 total bone marrow cells from CD11c-DTR
mice 6 hours after irradiation. Mice were allowed to reconstitute for a minimum of 12 weeks
and reconstitution was evaluated by flow cytometry of congenic markers. 24 and 48 hours
prior to infection, mice were administered 4 ng/g of diphtheria toxin I.V. Depletion efficiency
was tested in each batch of chimeric mice prior to experimentation.
Flow cytometry of bladder tissue
At indicated timepoints, bladders were removed and minced with dissection scissors into tubes
containing digestion buffer kept at 4°C. Minced tissue was then incubated at 37°C in 1 mL of
digestion buffer containing 0.34 U/mL of Liberase TM (Roche) and 100 μg/mL of DNase in
PBS. Tubes were vigorously shaken by hand every 15 minutes. 45 minutes to one hour post-
incubation, when the tissue had a glassy, transparent appearance and was almost entirely
digested, digestion was stopped by adding several mL of PBS supplemented with 2% FBS and
0.2 μM EDTA. The entire bladder digest was passed through a 100 μM cell strainer to obtain a
single cell suspension. Gentle pressure was applied to any tissue remaining in the strainer. Sam-
ples were washed, Fc receptors blocked, and stained with antibodies listed in Table 2. Total cell
counts in the bladder were determined by the addition of AccuCheck Counting beads (Invitro-
gen) to a known volume of sample after staining, just prior to cytometer acquisition. Gating
strategies for all cell populations except for neutrophils are depicted in Fig 2. Neutrophils were
identified as MHC II-, CD11b+, Ly6G+, Ly6C-, SiglecF-, and F4/80-.
Flow cytometry of blood
To identify cell populations in the circulation, whole blood was incubated with BD PharmLyse,
(BD Bioscience) and subsequently stained with antibodies indicated in the Table 2. Samples
were acquired on a BD LSRFortessa using DIVA software and data were analyzed by FlowJo
(Treestar) software. Total cell counts in the blood were determined by the addition of Accu-
Check Counting beads (Invitrogen) to 10 μL of whole blood diluted in 1-step Fix/Lyse Solution
(eBioscience).
Monocyte bead labeling
In vivo bead labeling of classical and nonclassical monocytes was performed as previously
described [32]. Briefly, classical monocytes were labeled by I.V. administration of 200 μL clo-
dronate liposomes to transiently deplete all monocytes and then by I.V. injection of 1 μM non-
degradable fluorescent particles 24 hours later. Nonclassical monocytes were labeled by
injection of 1 μM nondegradable fluorescent particles without prior monocyte depletion.
Labeling efficiency was confirmed by flow cytometry.
Immune cell depletion
To deplete monocytes, wildtype C57BL/6 mice received I.V. injection of 200 μL of clodronate
liposomes (or PBS control liposomes) 15–18 hours prior to infection [35]. Anti-CSF1R anti-
body (2 mg/mL, clone AFS98, eBioscience) was used to deplete bladder-resident macrophages.
Animals received two I.V. injections, on consecutive days, of anti-CSF1R antibody or isotype
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control (clone eBR2a, eBioscience). We administered 400 μg/mouse on day 1 and 200 μg/
mouse on day 2, to decrease the impact on circulating monocytes. To deplete T cells, 100 μg of
CD4 (clone GK1.5, Bio X Cell) and 100 μg of CD8 (clone YTS 169.4, Bio X Cell) per mouse
were injected together intraperitoneally 24 hours prior to primary infection. 200 μg of isotype
control (clone LTF-2, Bio X Cell) per mouse was injected intraperitoneally. The depletion was
repeated 5 days post-infection, and once a week to maintain the depletion until challenge
infection.
Luminex MAP analysis
Mice were infected with UTI89 and bladders removed 24 hours P.I. Bladders were homoge-
nized with a handheld tissue grinder in 1 mL PBS on ice. After removal of a 100 μL aliquot to
calculate CFU by serial dilution, bladder homogenates were clarified by microcentrifugation
(13K, 4, 5 minutes) and stored at -80°C until assessment by Luminex Milliplex MAPMouse
Cytokine/Chemokine Magnetic Bead Panel, Premixed 32-Plex, according to the manufactur-
er’s recommendations (Merck Millipore) [11]. All samples were assessed together to avoid
inter-assay variability. Just prior to analysis, after thawing, samples were centrifuged a second
time to remove any cell debris.
Statistical analysis
GraphPad Prism was used to evaluate statistical significant. Graphs depict medians and statisti-
cal significance was determined by the nonparametric Mann-Whitney test.
Supporting Information
S1 Fig. DT-mediated DC ablation. Irradiated C57Bl/6 mice were reconstituted with bone
marrow from CD11c-DTR animals and allowed to rest for 12 weeks. Prior to infection, mice
were treated two times with PBS (-) or 4 ng/g diphtheria toxin (+). 24 hours post-treatment, a
cohort of animals were analyzed by flow cytometry to assess the extent of depletion in the blad-
der. Graph depicts the number of DCs in the bladder in PBS or DT treated mice. Each dot is
one mouse, lines are medians. Depletion efficiency was tested in each batch of chimeric mice
prior to experimentation, n = 2–4 mice per group.
(TIF)
S2 Fig. Bladder autofluorescence. (A) Gating strategy for whole bladder digests. Bladders
from naïve mice were processed as described in Materials and Methods. The entire bladder
preparation was acquired and live cells were gated based on their forward and side scatter
properties (top left). CD45+ cells were identified (top, middle), however, this population con-
tained a large contaminating cell population (gated in pink, top right), particularly when CD45
was conjugated to fluorophores that emit near the emission wavelength of GFP. To eliminate
the contaminating autofluorescent cells from our analyses, we selected single cells (FSC-W,
SSC-W) versus MHC II staining (bottom, left, middle). The autofluorescent population was
reduced by this strategy while immune cell populations remained (bottom, right) (B) Micro-
graph of the luminal surface of an en face whole mount prepared bladder stained only with
DAPI (blue) to reveal DNA, to illustrate the intrinsic autofluorescence in this tissue. (C)
Graphs depict the percentage decrease in the contaminating cell population (left) and the rela-
tive change in the myeloid cell populations in the bladder after each gating step (right, CD11b+
cells are derived from black gates and CD11c+ cells are derived from blue gates in (A), and con-
taminating cells are gated in pink).
(TIF)
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S3 Fig. Immune cell ablation. (A-B) Mice were treated with PBS or clodronate liposomes
(Clod) I.V. and 15–18 hours later, blood and bladder samples were obtained to evaluate
immune cell depletion. Graphs depict the percentage of (A) monocytes and neutrophils in
blood and (B) monocytes, macrophages, and DCs in the bladder after treatment. (C-D) Mice
received two injections of anti-CSF1R antibody (Ab) or control isotype antibody (Iso) and 24
hours post-treatment, naive bladders were isolated to evaluate immune cell depletion. Graphs
show the (C) percentage and cell number of macrophages and DCs in the bladder and (D) per-
centage of monocytes and neutrophils in the blood. (E) Mice were depleted of macrophages as
in (C-D), however, bladders were evaluated for repopulation by macrophages 4 weeks after
depletion, prior to challenge infection in additional cohorts of treated mice. Each dot repre-
sents one mouse. Experiments were repeated 2–4 times with 2–7 mice per group.
(TIF)
S4 Fig. CCR2-/- mice are not impaired in bacterial clearance after primary infection. Graph
depicts the CFU/bladder 24 hours post-primary infection in wildtype (WT) or CCR2-/- mice.
Experiment was repeated 2 times with 4–5 mice per group.
(TIFF)
S5 Fig. UPEC reservoirs are not altered in monocyte or macrophage depleted mice. Graphs
depict CFU/bladder arising from the primary infecting strain in an experiment in which (A)
monocytes or (B) macrophages were depleted prior to primary infection and then challenged
with an isogenic strain and sacrificed 24 hours post-challenge. Each dot represents one mouse.
Experiments were repeated 2–4 times with 2–7 mice per group.
(TIFF)
S6 Fig. Macrophage depletion does not impact cytokine expression post-primary infection.
Mice were depleted with anti-CSF1R antibody and infected with 1x107 CFU of UTI89 24 hours
after depletion. Mice were sacrificed 24 hours P.I. and bladders were homogenized. Samples
were stored at -80°C until all samples could be assessed together by Luminex multi-analyte pro-
filing, to avoid inter-assay variability. Graphs depict the expression levels of selected cytokines
in isotype antibody treated (black dots, red medians) and depleting-antibody treated (open cir-
cles, blue medians) mice. Analytes are grouped by high expression (top) to low or no expres-
sion (bottom). Each dot represents a mouse, experiment performed 2 times with 5 mice per
group and all data pooled.
(TIFF)
S7 Fig. Fluorescent UPEC strains. (A) Cytometry plots, gated on all CD45+ cells, depict GFP
fluorescence (gated in pink with percentages) in mice either uninfected or infected with
UTI89-GFP at 4 hours post-infection. (B) Fluorescence of UTI89-GFP and UTI89-marsRFP
was confirmed by microscopy. (C) The mouse urothelial cell line, NUC-1, was infected with
the parental UTI89, UTI89-GFP, or UTI89-RFP at an MOI of 1,10, or 100. Cells were lysed
and bacterial titers determined by serial dilution 30 minutes P.I. The percentage of invasion
refers to the number of bacteria obtained after infection x 100/number of bacteria in the inocu-
lum. (D) Mice were instilled with 1x107 CFU of UTI89, UTI89-GFP, or UTI89-RFP. CFU per
bladder were determined by serial dilution at 24 h P.I. Each dot represents one mouse. Experi-
ments were repeated 2 times.
(TIF)
S8 Fig. Increasing bacterial inoculum in a primary infection does not improve the response
to challenge infection. Female C57Bl/6 mice were instilled with 1x107, 1x108, or 1x109 CFU of
UPEC and challenged with 1x107 CFU after resolution of the primary infection as in Fig 1A.
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(A) Plot depicts CFU 24 hours post-primary infection. (B) Graph shows CFU 24 hours post-
challenge. Each dot represents one mouse. Experiments were repeated 2 times with 5–7 mice
per group.
(TIFF)
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